Clostridium Difficile Infection Treatment Market : Table of Content


  • Published On : Nov-2019 |
  • Pages : 160 Pages |
  • Format : Clostridium Difficile Infection Treatment Market Clostridium Difficile Infection Treatment Market Clostridium Difficile Infection Treatment Market Clostridium Difficile Infection Treatment Market

1. Executive Summary

    1.1. Market Outlook

    1.2. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market View Point

    3.1. Macro-Economic Factors

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity Analysis

        3.1.4. Trends

        3.1.5. Forecast Factors

4. Global Clostridium difficile Infection Treatment Market (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

    4.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

    4.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

        4.2.3. Market Value Comparison

5. Global Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Type 

    5.1. Introduction / Key Findings

    5.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2014-2018

    5.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2019 - 2029

        5.3.1. Metronidazole

        5.3.2. Vancomycin

        5.3.3. Fidaxomicin

    5.4. Market Attractiveness Analysis By Drug Type

6. Global Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Route of Administration

    6.1. Introduction / Key Findings

    6.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014-2018

    6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2019 - 2029

        6.3.1. Oral

        6.3.2. Injectable

Market Attractiveness Analysis By Route of Administration 

7. Global Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018

    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2029

        7.3.1. Hospital Pharmacies

        7.3.2. Retail Pharmacies

        7.3.3. Mail Order Pharmacies

    7.4. Market Attractiveness Analysis By Distribution Channel 

8. Global Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Region 

    8.1. Introduction

    8.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018

    8.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia

        8.3.5. Middle East & Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    9.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

        9.3.1.  By Country

            9.3.1.1. U.S.

            9.3.1.2. Canada

        9.3.2. By Drug Type

        9.3.3. By Route of Administration

        9.3.4. By Distribution Channel

    9.4. Market Attractiveness Analysis

        9.4.1. By Country

        9.4.2. By Drug Type

        9.4.3. By Route of Administration

        9.4.4. By Distribution Channel

    9.5. Drivers and Restraints: Impact Analysis

10. Latin America Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

        10.3.1.  By Country

            10.3.1.1. Brazil

            10.3.1.2. Mexico

            10.3.1.3. Rest of Latin America

        10.3.2. By Drug Type

        10.3.3. By Route of Administration

        10.3.4. By Distribution Channel

    10.4. Market Attractiveness Analysis

        10.4.1. By Country

        10.4.2. By Drug Type

        10.4.3. By Route of Administration

        10.4.4. By Distribution Channel

    10.5. Drivers and Restraints: Impact Analysis

11. Europe Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

        11.3.1.  By Country

            11.3.1.1. Germany

            11.3.1.2. Italy

            11.3.1.3. France

            11.3.1.4. U.K.

            11.3.1.5. Spain

            11.3.1.6. Russia

            11.3.1.7. Rest of Europe

        11.3.2. By Drug Type

        11.3.3. By Route of Administration

        11.3.4. By Distribution Channel

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Drug Type

        11.4.3. By Route of Administration

        11.4.4. By Distribution Channel

    11.5. Drivers and Restraints: Impact Analysis

12. Asia Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

        12.3.1.  By Country

            12.3.1.1. Japan

            12.3.1.2. China

            12.3.1.3. India

            12.3.1.4. ASEAN

            12.3.1.5. Australia & New Zealand

            12.3.1.6. Rest of Asia Pacific

        12.3.2. By Drug Type

        12.3.3. By Route of Administration

        12.3.4. By Distribution Channel

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Drug Type

        12.4.3. By Route of Administration

        12.4.4. By Distribution Channel

    12.5. Drivers and Restraints: Impact Analysis

13. Middle East & Africa Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

        13.3.1. By Country

            13.3.1.1. GCC Countries

            13.3.1.2. South Africa

            13.3.1.3. North Africa

            13.3.1.4. Rest of MEA

        13.3.2. By Drug Type

        13.3.3. By Route of Administration

        13.3.4. By Distribution Channel

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Drug Type

        13.4.3. By Route of Administration

        13.4.4. By Distribution Channel

    13.5. Drivers and Restraints: Impact Analysis

14. Competition Analysis

    14.1. Competition Dashboard

    14.2. Competition Deep Dive 

        14.2.1. Merck & Co., Inc

            14.2.1.1. Overview

            14.2.1.2. Drug Portfolio

            14.2.1.3. Profitability by Market Segments (Drug/Channel/Region)

            14.2.1.4. Sales Footprint

            14.2.1.5. Strategy Overview

                14.2.1.5.1. Marketing Strategy

                14.2.1.5.2. Drug Strategy

                14.2.1.5.3. Channel Strategy

        14.2.2. Baxter International Inc.

            14.2.2.1. Overview

            14.2.2.2. Drug Portfolio

            14.2.2.3. Profitability by Market Segments (Drug/Channel/Region)

            14.2.2.4. Sales Footprint

            14.2.2.5. Strategy Overview

                14.2.2.5.1. Marketing Strategy

                14.2.2.5.2. Drug Strategy

                14.2.2.5.3. Channel Strategy

        14.2.3. Sanofi S.A.

            14.2.3.1. Overview

            14.2.3.2. Drug Portfolio

            14.2.3.3. Profitability by Market Segments (Drug/Channel/Region)

            14.2.3.4. Sales Footprint

            14.2.3.5. Strategy Overview

                14.2.3.5.1. Marketing Strategy

                14.2.3.5.2. Drug Strategy

                14.2.3.5.3. Channel Strategy

        14.2.4. Pfizer Inc.

            14.2.4.1. Overview

            14.2.4.2. Drug Portfolio

            14.2.4.3. Profitability by Market Segments (Drug/Channel/Region)

            14.2.4.4. Sales Footprint

            14.2.4.5. Strategy Overview

                14.2.4.5.1. Marketing Strategy

                14.2.4.5.2. Drug Strategy

                14.2.4.5.3. Channel Strategy

        14.2.5. Novartis AG

            14.2.5.1. Overview

            14.2.5.2. Drug Portfolio

            14.2.5.3. Profitability by Market Segments (Drug/Channel/Region)

            14.2.5.4. Sales Footprint

            14.2.5.5. Strategy Overview

                14.2.5.5.1. Marketing Strategy

                14.2.5.5.2. Drug Strategy

                14.2.5.5.3. Channel Strategy

        14.2.6. Astellas Pharma

            14.2.6.1. Overview

            14.2.6.2. Drug Portfolio

            14.2.6.3. Profitability by Market Segments (Drug/Channel/Region)

            14.2.6.4. Sales Footprint

            14.2.6.5. Strategy Overview

                14.2.6.5.1. Marketing Strategy

                14.2.6.5.2. Drug Strategy

                14.2.6.5.3. Channel Strategy

        14.2.7. Eli LilIy & Company

            14.2.7.1. Overview

            14.2.7.2. Drug Portfolio

            14.2.7.3. Profitability by Market Segments (Drug/Channel/Region)

            14.2.7.4. Sales Footprint

            14.2.7.5. Strategy Overview

                14.2.7.5.1. Marketing Strategy

                14.2.7.5.2. Drug Strategy

                14.2.7.5.3. Channel Strategy

        14.2.8. AstraZeneca

            14.2.8.1. Overview

            14.2.8.2. Drug Portfolio

            14.2.8.3. Profitability by Market Segments (Drug/Channel/Region)

            14.2.8.4. Sales Footprint

            14.2.8.5. Strategy Overview

                14.2.8.5.1. Marketing Strategy

                14.2.8.5.2. Drug Strategy

                14.2.8.5.3. Channel Strategy

        14.2.9. Actelion Pharmaceuticals Ltd (Sub. of Johnson & Johnson Services, Inc.) 

            14.2.9.1. Overview

            14.2.9.2. Drug Portfolio

            14.2.9.3. Profitability by Market Segments (Drug/Channel/Region)

            14.2.9.4. Sales Footprint

            14.2.9.5. Strategy Overview

                14.2.9.5.1. Marketing Strategy

                14.2.9.5.2. Drug Strategy

                14.2.9.5.3. Channel Strategy

        14.2.10. Mylan N.V.

            14.2.10.1. Overview

            14.2.10.2. Drug Portfolio

            14.2.10.3. Profitability by Market Segments (Drug/Channel/Region)

            14.2.10.4. Sales Footprint

            14.2.10.5. Strategy Overview

                14.2.10.5.1. Marketing Strategy

                14.2.10.5.2. Drug Strategy

                14.2.10.5.3. Channel Strategy

15. Assumptions and Acronyms Used

16. Research Methodology


List of Table

Table 01: Clostridium difficile Infection Treatment Market Value (US$ Mn) Growth Comparison

Table 02: Global Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type

Table 03: Global Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration

Table 04: Global Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel

Table 05: Global Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Region

Table 06: North America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country

Table 07: North America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type

Table 08: North America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration

Table 09: North America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel

Table 10: Latin America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country

Table 11: Latin America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type

Table 12: Latin America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration

Table 13: Latin America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel

Table 14: Europe Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country

Table 15: Europe Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type

Table 16: Europe Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration

Table 17: Europe Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel

Table 18: Asia Pacific Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country

Table 19: Asia Pacific Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type

Table 20: Asia Pacific Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration

Table 21: Asia Pacific Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel

Table 22: MEA Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country

Table 23: MEA Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type

Table 24: MEA Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration

Table 25: MEA Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel


List of Figure

Figure 01: Global Clostridium difficile Infection Treatment Market Value Share, By Drug Type (2019E)

Figure 02: Global Clostridium difficile Infection Treatment Market Value Share, By Route of Administration (2019E)

Figure 03: Global Clostridium difficile Infection Treatment Market Value Share, By Distribution Channel  (2019E)

Figure 04: Antimicrobial Drugs (AD) Use in Acute Care Hospitals in the U.S

Figure 05: Trends in Origin of C. difficile Infection in Europe (2017)

Figure 06: Antimicrobial Drugs (AD) Use in Acute Care Hospitals in the U.S

Figure 07: Global Clostridium difficile Infection Treatment Market Value Analysis (US$ Mn), 2014–2018

Figure 08: Incidence of C. difficile Infection Across Major Countries as Percentage of Total Hospital Admissions (2016)

Figure 08: Global Clostridium difficile Infection Treatment Market Value Forecast (US$ Mn), 2019–2029

Figure 09: Global Clostridium difficile Infection Treatment Market Absolute $ Opportunity, 2019–2029

Figure 10: Comparison January 2018 and November 2019, Y-o-Y Forecast

Figure 11: Global Clostridium difficile Infection Treatment Market Share Analysis (%), By Drug Type, 2019 & 2029

Figure 12: Global Clostridium difficile Infection Treatment Market Y-o-Y Analysis (%), By Drug Type, 2019–2029

Figure 13: Global Clostridium difficile Infection Treatment Market Attractiveness Analysis By Drug Type, 2019–2029

Figure 14: Global Clostridium difficile Infection Treatment Market Share Analysis (%), By Route of Administration, 2019 & 2029

Figure 15: Global Clostridium difficile Infection Treatment Market Y-o-Y Analysis (%), By Route of Administration, 2019–2029

Figure 16: Global Clostridium difficile Infection Treatment Market Attractiveness Analysis By Route of Administration, 2019–2029

Figure 17: Global Clostridium difficile Infection Treatment Market Share Analysis (%), By Distribution Channel, 2019 & 2029

Figure 18: Global Clostridium difficile Infection Treatment Market Y-o-Y Analysis (%), By Distribution Channel, 2019–2029

Figure 19: Global Clostridium difficile Infection Treatment Market Attractiveness Analysis Distribution Channel, 2019–2029

Figure 20: Global Clostridium difficile Infection Treatment Market Share Analysis (%), By Region, 2019 & 2029

Figure 21: Global Clostridium difficile Infection Treatment Market Y-o-Y Analysis (%), By Region, 2019–2029

Figure 22: Global Clostridium difficile Infection Treatment Market Attractiveness Analysis, By Region, 2019–2029

Figure 23: North America Clostridium difficile Infection Treatment Market Value Share, By Drug Type, 2019 (E)

Figure 24: North America Clostridium difficile Infection Treatment Market Value Share, By Route of Administration, 2019 (E)

Figure 25: North America Clostridium difficile Infection Treatment Market Value Share, By Distribution Channel, 2019 (E)

Figure 26: North America Clostridium difficile Infection Treatment Market Value Share, By Country, 2019 (E)

Figure 27: North America Clostridium difficile Infection Treatment Market Forecast 2019 and 2029

Figure 28: North America Clostridium difficile Infection Treatment Market Value Analysis (US$ Mn), 2014–2018

Figure 29: North America Clostridium difficile Infection Treatment Market Value Forecast (US$ Mn), 2019–2029

Figure 30: North America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Drug Type, 2019–2029

Figure 31: North America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Route of Administration, 2019–2029

Figure 31: North America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029

Figure 33: North America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Country, 2019–2029

Figure 34: Latin America Clostridium difficile Infection Treatment Market Value Share, By Drug Type, 2019 (E)

Figure 35: Latin America Clostridium difficile Infection Treatment Market Value Share, By Route of Administration, 2019 (E)

Figure 36: Latin America Clostridium difficile Infection Treatment Market Value Share, By Distribution Channel, 2019 (E)

Figure 37: Latin America Clostridium difficile Infection Treatment Market Value Share, By Country, 2019 (E)

Figure 38: Latin America Clostridium difficile Infection Treatment Market Forecast 2019 and 2029

Figure 40: Latin America Clostridium difficile Infection Treatment Market Value Forecast (US$ Mn), 2019–2029

Figure 41: Latin America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Drug Type, 2019–2029

Figure 42: Latin America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Route of Administration, 2019–2029

Figure 43: Latin America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029

Figure 44: Latin America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Country, 2019–2029

Figure 45: Europe Clostridium difficile Infection Treatment Market Value Share, By Drug Type, 2019 (E)

Figure 46: Europe Clostridium difficile Infection Treatment Market Value Share, By Route of Administration, 2019 (E)

Figure 47: Europe  Clostridium difficile Infection Treatment Market Value Share, By Distribution Channel, 2019 (E)

Figure 48: Europe  Clostridium difficile Infection Treatment Market Value Share, By Country, 2019 (E)

Figure 49: Europe  Clostridium difficile Infection Treatment Market Forecast 2019 and 2029

Figure 50: Europe  Clostridium difficile Infection Treatment Market Value Analysis (US$ Mn), 2014–2018

Figure 51: Europe  Clostridium difficile Infection Treatment Market Value Forecast (US$ Mn), 2019–2029

Figure 52: Europe  Clostridium difficile Infection Treatment Market Attractiveness Analysis By Drug Type, 2019–2029

Figure 53: Europe  Clostridium difficile Infection Treatment Market Attractiveness Analysis By Route of Administration, 2019–2029

Figure 54: Europe  Clostridium difficile Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029

Figure 55: Europe  Clostridium difficile Infection Treatment Market Attractiveness Analysis By Country, 2019–2029

Figure 56: Asia Pacific Clostridium difficile Infection Treatment Market Value Share, By Drug Type, 2019 (E)

Figure 57: Asia Pacific Clostridium difficile Infection Treatment Market Value Share, By Route of Administration, 2019 (E)

Figure 58: Asia Pacific Clostridium difficile Infection Treatment Market Value Share, By Distribution Channel, 2019 (E)

Figure 59: Asia Pacific Clostridium difficile Infection Treatment Market Value Share, By Country, 2019 (E)

Figure 60: Asia Pacific Clostridium difficile Infection Treatment Market Forecast 2019 and 2029

Figure 61: Asia Pacific Clostridium difficile Infection Treatment Market Value Analysis (US$ Mn), 2014–2018

Figure 62: Asia Pacific Clostridium difficile Infection Treatment Market Value Forecast (US$ Mn), 2019–2029

Figure 63: Asia Pacific Clostridium difficile Infection Treatment Market Attractiveness Analysis By Drug Type, 2019–2029

Figure 64: Asia Pacific Clostridium difficile Infection Treatment Market Attractiveness Analysis By Route of Administration, 2019–2029

Figure 65: Asia Pacific Clostridium difficile Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029

Figure 66: Asia Pacific Clostridium difficile Infection Treatment Market Attractiveness Analysis By Country, 2019–2029

Figure 67: MEA Clostridium difficile Infection Treatment Market Value Share, By Drug Type, 2019 (E)

Figure 68: MEA Clostridium difficile Infection Treatment Market Value Share, By Route of Administration, 2019 (E)

Figure 69: MEA Clostridium difficile Infection Treatment Market Value Share, By Distribution Channel, 2019 (E)

Figure 70: MEA Clostridium difficile Infection Treatment Market Value Share, By Country, 2019 (E)

Figure 71: MEA Clostridium difficile Infection Treatment Market Forecast 2019 and 2029

Figure 72: MEA Clostridium difficile Infection Treatment Market Value Analysis (US$ Mn), 2014–2018

Figure 73: MEA Clostridium difficile Infection Treatment Market Value Forecast (US$ Mn), 2019–2029

Figure 74: MEA Clostridium difficile Infection Treatment Market Attractiveness Analysis By Drug Type, 2019–2029

Figure 75: MEA Clostridium difficile Infection Treatment Market Attractiveness Analysis By Route of Administration, 2019–2029

Figure 76: MEA Clostridium difficile Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029

Figure 77: MEA Clostridium difficile Infection Treatment Market Attractiveness Analysis By Country, 2019–2029

Clostridium Difficile Infection Treatment Market - Table of Content

Back To Top